[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Sexually Transmitted Diseases (STD) Testing Market Growth (Status and Outlook) 2024-2030

March 2024 | 112 pages | ID: G1D1BC62F17EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global Sexually Transmitted Diseases (STD) Testing market size was valued at US$ 76750 million in 2023. With growing demand in downstream market, the Sexually Transmitted Diseases (STD) Testing is forecast to a readjusted size of US$ 96460 million by 2030 with a CAGR of 3.3% during review period.

The research report highlights the growth potential of the global Sexually Transmitted Diseases (STD) Testing market. Sexually Transmitted Diseases (STD) Testing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Sexually Transmitted Diseases (STD) Testing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Sexually Transmitted Diseases (STD) Testing market.

Sexually Transmitted Diseases (STD) Testing is used to detect all kinds of Sexually Transmitted virus.Sexually transmitted diseases are considered as one of the most critical health challenges globally. Chlamydia, gonorrhea, and herpes simplex virus are some of the highly prevalent sexually transmitted diseases.

Key Features:

The report on Sexually Transmitted Diseases (STD) Testing market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Sexually Transmitted Diseases (STD) Testing market. It may include historical data, market segmentation by Type (e.g., Chlamydia, Syphilis), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Sexually Transmitted Diseases (STD) Testing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Sexually Transmitted Diseases (STD) Testing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Sexually Transmitted Diseases (STD) Testing industry. This include advancements in Sexually Transmitted Diseases (STD) Testing technology, Sexually Transmitted Diseases (STD) Testing new entrants, Sexually Transmitted Diseases (STD) Testing new investment, and other innovations that are shaping the future of Sexually Transmitted Diseases (STD) Testing.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Sexually Transmitted Diseases (STD) Testing market. It includes factors influencing customer ' purchasing decisions, preferences for Sexually Transmitted Diseases (STD) Testing product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Sexually Transmitted Diseases (STD) Testing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Sexually Transmitted Diseases (STD) Testing market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Sexually Transmitted Diseases (STD) Testing market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Sexually Transmitted Diseases (STD) Testing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Sexually Transmitted Diseases (STD) Testing market.

Market Segmentation:

Sexually Transmitted Diseases (STD) Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type
  • Chlamydia
  • Syphilis
  • Gonorrhea
  • Herpes Simplex Virus
  • Human Papilloma Virus
  • Human Immunodeficiency Virus
  • Others
Segmentation by application
  • Laboratory Testing
  • Point of Care (POC) Testing
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • ROCHE HOLDINGS
  • BIOMERIEUX
  • HOLOGIC
  • BECTON DICKINSON
  • ORASURE
  • DANAHER
  • AFFYMETRIX
  • ABBOTT LABORATORIES
  • BIO-RAD LABORATORIES
  • DIASORIN
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Sexually Transmitted Diseases (STD) Testing Market Size 2019-2030
  2.1.2 Sexually Transmitted Diseases (STD) Testing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Sexually Transmitted Diseases (STD) Testing Segment by Type
  2.2.1 Chlamydia
  2.2.2 Syphilis
  2.2.3 Gonorrhea
  2.2.4 Herpes Simplex Virus
  2.2.5 Human Papilloma Virus
  2.2.6 Human Immunodeficiency Virus
  2.2.7 Others
2.3 Sexually Transmitted Diseases (STD) Testing Market Size by Type
  2.3.1 Sexually Transmitted Diseases (STD) Testing Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Type (2019-2024)
2.4 Sexually Transmitted Diseases (STD) Testing Segment by Application
  2.4.1 Laboratory Testing
  2.4.2 Point of Care (POC) Testing
2.5 Sexually Transmitted Diseases (STD) Testing Market Size by Application
  2.5.1 Sexually Transmitted Diseases (STD) Testing Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Application (2019-2024)

3 SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET SIZE BY PLAYER

3.1 Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Players
  3.1.1 Global Sexually Transmitted Diseases (STD) Testing Revenue by Players (2019-2024)
  3.1.2 Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Players (2019-2024)
3.2 Global Sexually Transmitted Diseases (STD) Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 SEXUALLY TRANSMITTED DISEASES (STD) TESTING BY REGIONS

4.1 Sexually Transmitted Diseases (STD) Testing Market Size by Regions (2019-2024)
4.2 Americas Sexually Transmitted Diseases (STD) Testing Market Size Growth (2019-2024)
4.3 APAC Sexually Transmitted Diseases (STD) Testing Market Size Growth (2019-2024)
4.4 Europe Sexually Transmitted Diseases (STD) Testing Market Size Growth (2019-2024)
4.5 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Sexually Transmitted Diseases (STD) Testing Market Size by Country (2019-2024)
5.2 Americas Sexually Transmitted Diseases (STD) Testing Market Size by Type (2019-2024)
5.3 Americas Sexually Transmitted Diseases (STD) Testing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Sexually Transmitted Diseases (STD) Testing Market Size by Region (2019-2024)
6.2 APAC Sexually Transmitted Diseases (STD) Testing Market Size by Type (2019-2024)
6.3 APAC Sexually Transmitted Diseases (STD) Testing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Sexually Transmitted Diseases (STD) Testing by Country (2019-2024)
7.2 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Type (2019-2024)
7.3 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Sexually Transmitted Diseases (STD) Testing by Region (2019-2024)
8.2 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Type (2019-2024)
8.3 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET FORECAST

10.1 Global Sexually Transmitted Diseases (STD) Testing Forecast by Regions (2025-2030)
  10.1.1 Global Sexually Transmitted Diseases (STD) Testing Forecast by Regions (2025-2030)
  10.1.2 Americas Sexually Transmitted Diseases (STD) Testing Forecast
  10.1.3 APAC Sexually Transmitted Diseases (STD) Testing Forecast
  10.1.4 Europe Sexually Transmitted Diseases (STD) Testing Forecast
  10.1.5 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Forecast
10.2 Americas Sexually Transmitted Diseases (STD) Testing Forecast by Country (2025-2030)
  10.2.1 United States Sexually Transmitted Diseases (STD) Testing Market Forecast
  10.2.2 Canada Sexually Transmitted Diseases (STD) Testing Market Forecast
  10.2.3 Mexico Sexually Transmitted Diseases (STD) Testing Market Forecast
  10.2.4 Brazil Sexually Transmitted Diseases (STD) Testing Market Forecast
10.3 APAC Sexually Transmitted Diseases (STD) Testing Forecast by Region (2025-2030)
  10.3.1 China Sexually Transmitted Diseases (STD) Testing Market Forecast
  10.3.2 Japan Sexually Transmitted Diseases (STD) Testing Market Forecast
  10.3.3 Korea Sexually Transmitted Diseases (STD) Testing Market Forecast
  10.3.4 Southeast Asia Sexually Transmitted Diseases (STD) Testing Market Forecast
  10.3.5 India Sexually Transmitted Diseases (STD) Testing Market Forecast
  10.3.6 Australia Sexually Transmitted Diseases (STD) Testing Market Forecast
10.4 Europe Sexually Transmitted Diseases (STD) Testing Forecast by Country (2025-2030)
  10.4.1 Germany Sexually Transmitted Diseases (STD) Testing Market Forecast
  10.4.2 France Sexually Transmitted Diseases (STD) Testing Market Forecast
  10.4.3 UK Sexually Transmitted Diseases (STD) Testing Market Forecast
  10.4.4 Italy Sexually Transmitted Diseases (STD) Testing Market Forecast
  10.4.5 Russia Sexually Transmitted Diseases (STD) Testing Market Forecast
10.5 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Forecast by Region (2025-2030)
  10.5.1 Egypt Sexually Transmitted Diseases (STD) Testing Market Forecast
  10.5.2 South Africa Sexually Transmitted Diseases (STD) Testing Market Forecast
  10.5.3 Israel Sexually Transmitted Diseases (STD) Testing Market Forecast
  10.5.4 Turkey Sexually Transmitted Diseases (STD) Testing Market Forecast
  10.5.5 GCC Countries Sexually Transmitted Diseases (STD) Testing Market Forecast
10.6 Global Sexually Transmitted Diseases (STD) Testing Forecast by Type (2025-2030)
10.7 Global Sexually Transmitted Diseases (STD) Testing Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 ROCHE HOLDINGS
  11.1.1 ROCHE HOLDINGS Company Information
  11.1.2 ROCHE HOLDINGS Sexually Transmitted Diseases (STD) Testing Product Offered
  11.1.3 ROCHE HOLDINGS Sexually Transmitted Diseases (STD) Testing Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 ROCHE HOLDINGS Main Business Overview
  11.1.5 ROCHE HOLDINGS Latest Developments
11.2 BIOMERIEUX
  11.2.1 BIOMERIEUX Company Information
  11.2.2 BIOMERIEUX Sexually Transmitted Diseases (STD) Testing Product Offered
  11.2.3 BIOMERIEUX Sexually Transmitted Diseases (STD) Testing Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 BIOMERIEUX Main Business Overview
  11.2.5 BIOMERIEUX Latest Developments
11.3 HOLOGIC
  11.3.1 HOLOGIC Company Information
  11.3.2 HOLOGIC Sexually Transmitted Diseases (STD) Testing Product Offered
  11.3.3 HOLOGIC Sexually Transmitted Diseases (STD) Testing Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 HOLOGIC Main Business Overview
  11.3.5 HOLOGIC Latest Developments
11.4 BECTON DICKINSON
  11.4.1 BECTON DICKINSON Company Information
  11.4.2 BECTON DICKINSON Sexually Transmitted Diseases (STD) Testing Product Offered
  11.4.3 BECTON DICKINSON Sexually Transmitted Diseases (STD) Testing Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 BECTON DICKINSON Main Business Overview
  11.4.5 BECTON DICKINSON Latest Developments
11.5 ORASURE
  11.5.1 ORASURE Company Information
  11.5.2 ORASURE Sexually Transmitted Diseases (STD) Testing Product Offered
  11.5.3 ORASURE Sexually Transmitted Diseases (STD) Testing Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 ORASURE Main Business Overview
  11.5.5 ORASURE Latest Developments
11.6 DANAHER
  11.6.1 DANAHER Company Information
  11.6.2 DANAHER Sexually Transmitted Diseases (STD) Testing Product Offered
  11.6.3 DANAHER Sexually Transmitted Diseases (STD) Testing Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 DANAHER Main Business Overview
  11.6.5 DANAHER Latest Developments
11.7 AFFYMETRIX
  11.7.1 AFFYMETRIX Company Information
  11.7.2 AFFYMETRIX Sexually Transmitted Diseases (STD) Testing Product Offered
  11.7.3 AFFYMETRIX Sexually Transmitted Diseases (STD) Testing Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 AFFYMETRIX Main Business Overview
  11.7.5 AFFYMETRIX Latest Developments
11.8 ABBOTT LABORATORIES
  11.8.1 ABBOTT LABORATORIES Company Information
  11.8.2 ABBOTT LABORATORIES Sexually Transmitted Diseases (STD) Testing Product Offered
  11.8.3 ABBOTT LABORATORIES Sexually Transmitted Diseases (STD) Testing Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 ABBOTT LABORATORIES Main Business Overview
  11.8.5 ABBOTT LABORATORIES Latest Developments
11.9 BIO-RAD LABORATORIES
  11.9.1 BIO-RAD LABORATORIES Company Information
  11.9.2 BIO-RAD LABORATORIES Sexually Transmitted Diseases (STD) Testing Product Offered
  11.9.3 BIO-RAD LABORATORIES Sexually Transmitted Diseases (STD) Testing Revenue, Gross Margin and Market Share (2019-2024)
  11.9.4 BIO-RAD LABORATORIES Main Business Overview
  11.9.5 BIO-RAD LABORATORIES Latest Developments
11.10 DIASORIN
  11.10.1 DIASORIN Company Information
  11.10.2 DIASORIN Sexually Transmitted Diseases (STD) Testing Product Offered
  11.10.3 DIASORIN Sexually Transmitted Diseases (STD) Testing Revenue, Gross Margin and Market Share (2019-2024)
  11.10.4 DIASORIN Main Business Overview
  11.10.5 DIASORIN Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Sexually Transmitted Diseases (STD) Testing Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Chlamydia
Table 3. Major Players of Syphilis
Table 4. Major Players of Gonorrhea
Table 5. Major Players of Herpes Simplex Virus
Table 6. Major Players of Human Papilloma Virus
Table 7. Major Players of Human Immunodeficiency Virus
Table 8. Major Players of Others
Table 9. Sexually Transmitted Diseases (STD) Testing Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Sexually Transmitted Diseases (STD) Testing Market Size by Type (2019-2024) & ($ Millions)
Table 11. Global Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Type (2019-2024)
Table 12. Sexually Transmitted Diseases (STD) Testing Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 13. Global Sexually Transmitted Diseases (STD) Testing Market Size by Application (2019-2024) & ($ Millions)
Table 14. Global Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Application (2019-2024)
Table 15. Global Sexually Transmitted Diseases (STD) Testing Revenue by Players (2019-2024) & ($ Millions)
Table 16. Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Player (2019-2024)
Table 17. Sexually Transmitted Diseases (STD) Testing Key Players Head office and Products Offered
Table 18. Sexually Transmitted Diseases (STD) Testing Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Sexually Transmitted Diseases (STD) Testing Market Size by Regions 2019-2024 & ($ Millions)
Table 22. Global Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Regions (2019-2024)
Table 23. Global Sexually Transmitted Diseases (STD) Testing Revenue by Country/Region (2019-2024) & ($ millions)
Table 24. Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Country/Region (2019-2024)
Table 25. Americas Sexually Transmitted Diseases (STD) Testing Market Size by Country (2019-2024) & ($ Millions)
Table 26. Americas Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Country (2019-2024)
Table 27. Americas Sexually Transmitted Diseases (STD) Testing Market Size by Type (2019-2024) & ($ Millions)
Table 28. Americas Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Type (2019-2024)
Table 29. Americas Sexually Transmitted Diseases (STD) Testing Market Size by Application (2019-2024) & ($ Millions)
Table 30. Americas Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Application (2019-2024)
Table 31. APAC Sexually Transmitted Diseases (STD) Testing Market Size by Region (2019-2024) & ($ Millions)
Table 32. APAC Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Region (2019-2024)
Table 33. APAC Sexually Transmitted Diseases (STD) Testing Market Size by Type (2019-2024) & ($ Millions)
Table 34. APAC Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Type (2019-2024)
Table 35. APAC Sexually Transmitted Diseases (STD) Testing Market Size by Application (2019-2024) & ($ Millions)
Table 36. APAC Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Application (2019-2024)
Table 37. Europe Sexually Transmitted Diseases (STD) Testing Market Size by Country (2019-2024) & ($ Millions)
Table 38. Europe Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Country (2019-2024)
Table 39. Europe Sexually Transmitted Diseases (STD) Testing Market Size by Type (2019-2024) & ($ Millions)
Table 40. Europe Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Type (2019-2024)
Table 41. Europe Sexually Transmitted Diseases (STD) Testing Market Size by Application (2019-2024) & ($ Millions)
Table 42. Europe Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Application (2019-2024)
Table 43. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Region (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Region (2019-2024)
Table 45. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Type (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Type (2019-2024)
Table 47. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Application (2019-2024) & ($ Millions)
Table 48. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Application (2019-2024)
Table 49. Key Market Drivers & Growth Opportunities of Sexually Transmitted Diseases (STD) Testing
Table 50. Key Market Challenges & Risks of Sexually Transmitted Diseases (STD) Testing
Table 51. Key Industry Trends of Sexually Transmitted Diseases (STD) Testing
Table 52. Global Sexually Transmitted Diseases (STD) Testing Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 53. Global Sexually Transmitted Diseases (STD) Testing Market Size Market Share Forecast by Regions (2025-2030)
Table 54. Global Sexually Transmitted Diseases (STD) Testing Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 55. Global Sexually Transmitted Diseases (STD) Testing Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 56. ROCHE HOLDINGS Details, Company Type, Sexually Transmitted Diseases (STD) Testing Area Served and Its Competitors
Table 57. ROCHE HOLDINGS Sexually Transmitted Diseases (STD) Testing Product Offered
Table 58. ROCHE HOLDINGS Sexually Transmitted Diseases (STD) Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 59. ROCHE HOLDINGS Main Business
Table 60. ROCHE HOLDINGS Latest Developments
Table 61. BIOMERIEUX Details, Company Type, Sexually Transmitted Diseases (STD) Testing Area Served and Its Competitors
Table 62. BIOMERIEUX Sexually Transmitted Diseases (STD) Testing Product Offered
Table 63. BIOMERIEUX Main Business
Table 64. BIOMERIEUX Sexually Transmitted Diseases (STD) Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. BIOMERIEUX Latest Developments
Table 66. HOLOGIC Details, Company Type, Sexually Transmitted Diseases (STD) Testing Area Served and Its Competitors
Table 67. HOLOGIC Sexually Transmitted Diseases (STD) Testing Product Offered
Table 68. HOLOGIC Main Business
Table 69. HOLOGIC Sexually Transmitted Diseases (STD) Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. HOLOGIC Latest Developments
Table 71. BECTON DICKINSON Details, Company Type, Sexually Transmitted Diseases (STD) Testing Area Served and Its Competitors
Table 72. BECTON DICKINSON Sexually Transmitted Diseases (STD) Testing Product Offered
Table 73. BECTON DICKINSON Main Business
Table 74. BECTON DICKINSON Sexually Transmitted Diseases (STD) Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. BECTON DICKINSON Latest Developments
Table 76. ORASURE Details, Company Type, Sexually Transmitted Diseases (STD) Testing Area Served and Its Competitors
Table 77. ORASURE Sexually Transmitted Diseases (STD) Testing Product Offered
Table 78. ORASURE Main Business
Table 79. ORASURE Sexually Transmitted Diseases (STD) Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. ORASURE Latest Developments
Table 81. DANAHER Details, Company Type, Sexually Transmitted Diseases (STD) Testing Area Served and Its Competitors
Table 82. DANAHER Sexually Transmitted Diseases (STD) Testing Product Offered
Table 83. DANAHER Main Business
Table 84. DANAHER Sexually Transmitted Diseases (STD) Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. DANAHER Latest Developments
Table 86. AFFYMETRIX Details, Company Type, Sexually Transmitted Diseases (STD) Testing Area Served and Its Competitors
Table 87. AFFYMETRIX Sexually Transmitted Diseases (STD) Testing Product Offered
Table 88. AFFYMETRIX Main Business
Table 89. AFFYMETRIX Sexually Transmitted Diseases (STD) Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. AFFYMETRIX Latest Developments
Table 91. ABBOTT LABORATORIES Details, Company Type, Sexually Transmitted Diseases (STD) Testing Area Served and Its Competitors
Table 92. ABBOTT LABORATORIES Sexually Transmitted Diseases (STD) Testing Product Offered
Table 93. ABBOTT LABORATORIES Main Business
Table 94. ABBOTT LABORATORIES Sexually Transmitted Diseases (STD) Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. ABBOTT LABORATORIES Latest Developments
Table 96. BIO-RAD LABORATORIES Details, Company Type, Sexually Transmitted Diseases (STD) Testing Area Served and Its Competitors
Table 97. BIO-RAD LABORATORIES Sexually Transmitted Diseases (STD) Testing Product Offered
Table 98. BIO-RAD LABORATORIES Main Business
Table 99. BIO-RAD LABORATORIES Sexually Transmitted Diseases (STD) Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. BIO-RAD LABORATORIES Latest Developments
Table 101. DIASORIN Details, Company Type, Sexually Transmitted Diseases (STD) Testing Area Served and Its Competitors
Table 102. DIASORIN Sexually Transmitted Diseases (STD) Testing Product Offered
Table 103. DIASORIN Main Business
Table 104. DIASORIN Sexually Transmitted Diseases (STD) Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. DIASORIN Latest Developments

LIST OF FIGURES

Figure 1. Sexually Transmitted Diseases (STD) Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Sexually Transmitted Diseases (STD) Testing Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Sexually Transmitted Diseases (STD) Testing Sales Market Share by Country/Region (2023)
Figure 8. Sexually Transmitted Diseases (STD) Testing Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Type in 2023
Figure 10. Sexually Transmitted Diseases (STD) Testing in Laboratory Testing
Figure 11. Global Sexually Transmitted Diseases (STD) Testing Market: Laboratory Testing (2019-2024) & ($ Millions)
Figure 12. Sexually Transmitted Diseases (STD) Testing in Point of Care (POC) Testing
Figure 13. Global Sexually Transmitted Diseases (STD) Testing Market: Point of Care (POC) Testing (2019-2024) & ($ Millions)
Figure 14. Global Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Application in 2023
Figure 15. Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Player in 2023
Figure 16. Global Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Sexually Transmitted Diseases (STD) Testing Market Size 2019-2024 ($ Millions)
Figure 18. APAC Sexually Transmitted Diseases (STD) Testing Market Size 2019-2024 ($ Millions)
Figure 19. Europe Sexually Transmitted Diseases (STD) Testing Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size 2019-2024 ($ Millions)
Figure 21. Americas Sexually Transmitted Diseases (STD) Testing Value Market Share by Country in 2023
Figure 22. United States Sexually Transmitted Diseases (STD) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Sexually Transmitted Diseases (STD) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Sexually Transmitted Diseases (STD) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Sexually Transmitted Diseases (STD) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Region in 2023
Figure 27. APAC Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Type in 2023
Figure 28. APAC Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Application in 2023
Figure 29. China Sexually Transmitted Diseases (STD) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Sexually Transmitted Diseases (STD) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Sexually Transmitted Diseases (STD) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Sexually Transmitted Diseases (STD) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Sexually Transmitted Diseases (STD) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Sexually Transmitted Diseases (STD) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Country in 2023
Figure 36. Europe Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Type (2019-2024)
Figure 37. Europe Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Application (2019-2024)
Figure 38. Germany Sexually Transmitted Diseases (STD) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Sexually Transmitted Diseases (STD) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Sexually Transmitted Diseases (STD) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Sexually Transmitted Diseases (STD) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Sexually Transmitted Diseases (STD) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Sexually Transmitted Diseases (STD) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Sexually Transmitted Diseases (STD) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Sexually Transmitted Diseases (STD) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Sexually Transmitted Diseases (STD) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Sexually Transmitted Diseases (STD) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Sexually Transmitted Diseases (STD) Testing Market Size 2025-2030 ($ Millions)
Figure 52. APAC Sexually Transmitted Diseases (STD) Testing Market Size 2025-2030 ($ Millions)
Figure 53. Europe Sexually Transmitted Diseases (STD) Testing Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size 2025-2030 ($ Millions)
Figure 55. United States Sexually Transmitted Diseases (STD) Testing Market Size 2025-2030 ($ Millions)
Figure 56. Canada Sexually Transmitted Diseases (STD) Testing Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Sexually Transmitted Diseases (STD) Testing Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Sexually Transmitted Diseases (STD) Testing Market Size 2025-2030 ($ Millions)
Figure 59. China Sexually Transmitted Diseases (STD) Testing Market Size 2025-2030 ($ Millions)
Figure 60. Japan Sexually Transmitted Diseases (STD) Testing Market Size 2025-2030 ($ Millions)
Figure 61. Korea Sexually Transmitted Diseases (STD) Testing Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Sexually Transmitted Diseases (STD) Testing Market Size 2025-2030 ($ Millions)
Figure 63. India Sexually Transmitted Diseases (STD) Testing Market Size 2025-2030 ($ Millions)
Figure 64. Australia Sexually Transmitted Diseases (STD) Testing Market Size 2025-2030 ($ Millions)
Figure 65. Germany Sexually Transmitted Diseases (STD) Testing Market Size 2025-2030 ($ Millions)
Figure 66. France Sexually Transmitted Diseases (STD) Testing Market Size 2025-2030 ($ Millions)
Figure 67. UK Sexually Transmitted Diseases (STD) Testing Market Size 2025-2030 ($ Millions)
Figure 68. Italy Sexually Transmitted Diseases (STD) Testing Market Size 2025-2030 ($ Millions)
Figure 69. Russia Sexually Transmitted Diseases (STD) Testing Market Size 2025-2030 ($ Millions)
Figure 70. Spain Sexually Transmitted Diseases (STD) Testing Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Sexually Transmitted Diseases (STD) Testing Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Sexually Transmitted Diseases (STD) Testing Market Size 2025-2030 ($ Millions)
Figure 73. Israel Sexually Transmitted Diseases (STD) Testing Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Sexually Transmitted Diseases (STD) Testing Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Sexually Transmitted Diseases (STD) Testing Market Size 2025-2030 ($ Millions)
Figure 76. Global Sexually Transmitted Diseases (STD) Testing Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Sexually Transmitted Diseases (STD) Testing Market Size Market Share Forecast by Application (2025-2030)


More Publications